Article
Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications.
International journal of molecular sciences - 18 Jul 2026
Marafioti Mariapia, Patruno Margherita, Musarra Martina, Silvestris Nicola, Portillo Funes Jessica Alejandra, Omero Fausto, Sapuppo Elena, Cianci Vincenzo, Calabrò Marco, Irrera Natasha, Briuglia Silvana, Santarpia Mariacarmela, Speranza Desirèe
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with a rising incidence and a poor prognosis that largely reflects late-stage diagnosis. Although most cases are sporadic, approximately 5-10% of PDACs occur in the context of inherited cancer susceptibility, including hereditary pancreatic cancer (HPC) syndromes and familial pancreatic cancer (FPC). Germline pathogenic variants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
